TETugba Ercetin

Tugba Ercetin

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Tugba Ercetin has a total of 28 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Synthesis and In Vitro Evaluation of Novel Thiazole-Hydrazone Derivatives with Antioxidant and Cytotoxic Potential

    by Ebru Nur Ay, Tugba Ercetin, Ulviye Acar Çevik

    A new series of thiazole–hydrazone derivatives (2a–2l) was synthesized and evaluated for their in vitro antioxidant and cytotoxic properties. The structures of the synthesized compounds were confirmed by ¹H NMR, ¹³C NMR, and HRMS analyses. Antioxidant activity was assessed using the DPPH radical scavenging assay, while cytotoxicity was evaluated using the MTT assay in human colorectal cancer (HCT116) and non-small cell lung cancer (H460) cell lines. In the DPPH assay, compounds 2c and 2h exhibited the notable radical scavenging activity, with IC₅₀ values of 31.73 ± 0.004 μM and 31.13 ± 0.008 μM, respectively, comparable to the reference compound gallic acid (IC₅₀ = 29.48 ± 0.014 μM). Cytotoxicity screening performed at 100 μM for 24 h indicated that most derivatives did not significantly reduce cell viability in HCT116 cells. In contrast, a partial decrease in cell viability was observed in H460 cells for the selected compounds, with compound 2l showing a moderate effect (IC₅₀ = 82.00 ± 3.67 μM). The results indicate that the biological activity of these thiazole–hydrazone derivatives is strongly influenced by substitution patterns. While the compounds exhibited limited antiproliferative effects under the tested conditions, certain derivatives demonstrated notable antioxidant activity. These findings suggest that this scaffold may serve as a useful starting point for further structural optimization toward multifunctional bioactive molecules


  • Synthesis of Novel Benzofuran-Based Thiazole Hybrids and Investigation of Their Antioxidant and Anticholinesterase Activities

    by Betül Kaya, Zahra Maryam, Nour El-Huda Daoud, Emine Rana Bağci, Abdüllatif Karakaya, Tugba Ercetin, Ulviye Acar Çevik

    In this study, a novel series of benzofuran derivatives (2a-2k) were synthesized and the structures of the obtained compounds were elucidated by 1H NMR, 13C NMR and HRMS spectra. The compounds were investigated for their anticholinesterase and antioxidant potentials. The ferrous ion chelating activity of the compound 2g at 50 µM concentration was 68.25%, surpassing those of rutin and BHT (13.21% and 2.57%, respectively). Besides, according to DPPH radical scavenging activity assay, compound 2g exhibited the most potent antioxidant activity with an IC50 value of 30.14 ± 0.005 µM, when compared to standard gallic acid (IC50= 29.48 ± 0.014 µM). Furthermore, compounds 2d (10.33%) and 2i (20.17%), showed the highest inhibitory activity against AChE and BChE, respectively. Compound 2i exhibits important interactions with the active site of BChE, according to the in silico molecular docking study. Also, the in silico ADMET study revealed the desirable pharmacokinetic properties of compound 2i. Therefore, compounds 2g and 2i could be deemed as promising candidates for the designing dual functional antioxidant and butyrylcholinesterase inhibitors in the management of Alzheimer’s disease.


  • Open Access

    Synthesis of novel thiazole derivatives against Alzheimer’s disease and investigation of their cholinesterase inhibition and antioxidant properties

    by Abdüllatif Karakaya, Tuğba Erçetin, Ulviye Acar Çevik, Yusuf Özkay

    In this study, 7 new thiazole derivatives were synthesized. Cholinesterase inhibition and antioxidant properties were examined to understand whether the synthesized compounds were anti-Alzheimer drug candidates. The antioxidant properties of these newly synthesized thiazole derivatives and their enzyme inhibition values for acetylcholinesterase (AChE) and butyrylcholinesterase (BuChE) were evaluated. According to the data, these substances inhibited the AChE and BuChE enzymes at deficient levels. Compound 2e showed the highest AChE inhibition effect with a value of 20.32 ± 0.005% at 50 µM concentration. Although high activity against BuChE was not observed, compound 2d was an exception with a value of 32.54 ± 0.021% at 50 µM concentration. Values that were comparable to the reference medication gallic acid were found when the antioxidant qualities were investigated using DPPH and ferric ion chelation studies. Ferrous ion-chelating and DPPH radical scavenging consistent with all of the previously reported information, the compounds’ antioxidant properties were very high, despite their modest cholinesterase enzyme inhibitory capabilities. In terms of AChE inhibition and antioxidant activity, respectively, compounds 2e and 2f were shown to be promising prospective agents among these compounds’.

  • Open Access

    Synthesis, Characterization, of Antioxidant Activity Mannich Bases from 2-Benzoxalinones

    by Faika Başoğlu, Eda Becer, Tugba Ercetin, Hayrettin Ozan Gülcan

    This study aimed to synthesize a series of 3-substituted piperazinomethyl derivatives (BzO1-4) via a Mannich reaction and evaluate their antioxidant activities using 2,2-diphenyl-1-picrylhydrazyl (DPPH) radical scavenging activity and ferrous ion- chelation capacity assays. The synthesis process involved precise techniques, and the compounds were characterized using elemental analysis, FT-IR, and 1H-NMR spectroscopy. Notably, BzO-1, featuring a 4-methylphenyl substituent, emerged as a novel compound within this series, demonstrating the highest antioxidant activity among the four derivatives tested. A considarable performance of BzO-1 was evident in its ability to neutralize free radicals and ferric ion-chelating capacity indicating its potential as a potent antioxidant agent. The detailed characterization data provided insights into the molecular structures and electronic environments of the synthesized compounds, which were crucial for understanding their antioxidant mechanisms. These findings suggest that the structural modifications in these piperazinomethyl derivatives significantly influence their antioxidant properties, and the novel BzO-1 compound holds promise for further development and application in antioxidant therapy.


  • Open Access

    Synthesis, Anticholinesterase and Antioxidant Activity of Thiosemicarbazone Derivatives

    by Betül Kaya, Ulviye Acar Çevik, Abdüllatif Karakaya, Tugba Ercetin

    In this research, we report the synthesis and evaluation of novel thiosemicarbazones as anti-Alzheimer’s agents. The structural clarification of the newly synthesized compounds was carried out by 1H NMR, 13C NMR, and MS analyses. According to the in vitro cholinesterase inhibition assay, compounds showed more inhibitory potential against AChE than BuChE. The in vitro antioxidant activity of the synthesized compounds was measured via two different methods. According to ferrous ion-chelating assay compound 2b demonstrated 5.26% activity when compared to BHT (2.57%). DPPH radical scavenging activity assay revealed that compound 2b showed the most potent antioxidant activity with an IC50 value of 43.91 ± 0.021μM. Among the synthesized compounds, compound 2b was found as the most potent antioxidant agent.


  • Open Access

    Synthesis of thiazole derivatives as cholinesterase inhibitors with antioxidant activity

    by Abdüllatif Karakaya, Zahra Maryam, Tugba Erceti̇n, Ulviye Acar Çevi̇k

    In the present research, we synthesized two unique series of thiazole compounds having 5-bromothiophene and 3-methylthiophene (2a-2f) in their structure. After that, spectroscopic methods were used to analyze the chemical compositions of the newly synthesized molecules. Then in vitro evaluation was done to determine acetylcholinesterase (AChE) and butyrylcholinesterase (BuChE) activity of the synthesized compounds using galantamine as reference standard. The compounds’ antioxidant properties were assessed using DPPH radical scavenging and ferrous ion-chelating techniques. The results of the study showed weak anticholinesterase activity against AChE and BuChE enzymes for all the final compounds. The synthesized analogs also showed significant DPPH radical scavenging activities with IC50 values in the range of 29.16 ± 0.009 to 33.09 ± 0.004 µM (for DDPH) incomparison to standard gallic acid with IC50 = 31.13 ± 0.008 µM (for DDPH). Especially, compound 2c showed the best antioxidant activity with IC50 value of 29.16 ± 0.009 µM.


  • Open Access

    Design, Synthesis and Evaluation of Pyrrol-thiazole Derivatives as AChE and BuChE Inhibitory and Antioxidant Activities

    by Ulviye Acar Çevi̇k, Tugba Erceti̇n

    Thiazole rings are one of the most frequently used heterocyclic moieties and are found in a wide variety of biologically active chemicals. In this research project, we report the synthesis and biological activities of some new thiazole derivatives (2a-2c) as potent anti-Alzheimer’s agents. These final compounds’ structures were characterized by spectral (1H NMR, 13C NMR, and MS spectra) analyses. The highest inhibitory activity against AChE was demonstrated by compound 2c (23.73 ± 0.018 %) with chloro substitution at the meta and para positions of the phenyl ring, while the highest inhibitory activity against BuChE was produced by compound 2a (28.87± 0.003 %) with cyano substitution at the f position of the phenyl ring. Ferrous ion-chelating and DPPH techniques were also used to assess the compounds' antioxidant properties. Compound 2a showed antioxidant effect according to the DPPH method with an IC50 value of 27.18 ± 0.009 µM.


  • Yeni tiyazol-hidrazinil türevlerinin sentezi, karakterizasyonu, moleküler doking ve kolinesteraz inhibisyon çalışmaları

    by Ulviye Acar Çevi̇k, Ayşen IŞIK, İsMail Çeli̇k, Tugba Erceti̇n

    Alzheimer hastalığı (AD), beyinde asetilkolin üreten veya kullanan kolinerjik hücrelerin yıkımı veya kaybından kaynaklanmaktadır. Bundan dolayı, AD için ana tedavi stratejisi beyindeki asetilkolin seviyesini arttırmaktır. Bu çalışmada, kolinesteraz inhibitörleri olarak yeni tiyazol-hidrazinil türevlerinin sentezi gerçekleştirilmiştir. Sentezlenen bileşiklerin yapısı 1H-NMR ve 13C-NMR verileri ile aydınlatılmıştır. Sentezlenen hedef bileşiklerin asetilkolinesteraz (AChE) ve butirilkolinesteraz (BChE) inhibitör etkileri Ellman yöntemi kullanılarak değerlendirilmiştir. Moleküler doking çalışması Autodock Vina ile yapılmıştır. Sentezlenen bütün bileşiklerin AChE karşı düşük etkinlik sergilediği bulunmuştur. Sentezlenen bileşikler arasından sadece bileşik 3j seçici olarak BuChE inhibe ettiği bulunmuştur. Dokingden elde edilen verilere göre bileşik 3j, BuChE aktif sitesinde 10.0 kcal/mol etkileşim enerjisi ve Trp82 ile anahtar pi-pi staked etkileşimleri oluşturmuştur. Sonuç olarak, bu çalışma Alzheimer hastalığının tedavisinde seçici BuChE inhibitörü ajan geliştirmede yol göstericidir.

  • Yeni Tiyazolil-Hidrazin Türevlerinin Sentezi ve Asetilkolinesteraz (AChE) ve Bütirilkolinesteraz (BuChE) Aktivite Çalışmaları

    by Ayşen IŞIK, Ulviye Acar Çevi̇k, Tugba Erceti̇n, Ahmet Koçak

    Alzheimer hastalığı (AH), zamanla beyin hücrelerinin ölümüne bağlı olarak bilişsel işlevlerde azalma, hafıza kaybı ve bunama ile ilişkilendirilmiştir. Alzheimer hastalığının tedavisinde sınırlayıcı uygulamaların mevcut oluşu, hastalığın sağlık harcamalarında kanser ve kalp hastalıklardan sonra dünyada üçüncü sırada oluşu araştırmacıları AH üzerinde erken evrede tanıma ve yeni tedavi yöntemlerine yönlendirmektedir. Günümüzde kolinerjik anomalikler ile AH arasında doğrudan bir ilişki olduğu düşünülmektedir. Çalışmalar, asetilkolinesteraz (AChE) ve bütirilkolinesteraz (BuChE) inhibisyonunun asetilkolin (ACh) seviyesinde meydana gelen artışların Alzheimer hastalığının başlangıç evrelerindeki bilişsel yetmezliği iyileştirebileceğini kanıtlamıştır. Dolayısıyla ACh düzeylerini arttırmak için uygulanacak en iyi metot ise, ACh’yi yıkan AChE veya BuChE enzimlerinin baskılanmasıdır. Dolayısıyla yapılan bu çalışmada, sübstitüe edilmiş tiyazolilhidrazin türevleri tasarlanmış, sentezlenmiş ve AH’ ye karşı asetilkolinesteraz (AChE) ve bütirilkolinesteraz (BuChE) kolinesteraz enzimlerinin inhibisyon potansiyelleri araştırılmıştır. Hedef bileşiklerin yapıları 1H NMR/13C NMR analiz yöntemleri ile aydınlatılmıştır. Hedef bileşiklerin AChE ve BuChE enzimleri üzerindeki inhibisyon etkileri Ellman yöntemiile değerlendirilmiş ve hedef bileşiklerin enzim inhibisyon çalışmaları sonucunda 3d bileşiğinin orta düzeyde bütirilkolinesteraz enzimini inhibe ettiği tespit edilmiştir.


  • Design, synthesis, and biological evaluation of new urolithin amides as multitarget agents against Alzheimer's disease

    by Karar T. Shukur, Tugba Ercetin, Chiara Luise, Wolfgang Sippl, Okan Sirkecioglu, Mert Ulgen, Goknil P. Coskun, Mine Yarim, Mustafa Gazi, Hayrettin O. Gulcan

    A series of urolithin amide (i.e., URO‐4–URO‐10 and THU‐4–THU‐10) derivatives was designed and synthesized, and their chemical structures were confirmed with spectroscopic techniques and elemental analysis. The title compounds and synthesis intermediates (THU‐1–THU‐10 and URO‐1–URO‐10) were evaluated for their potential to inhibit acetylcholinesterase (AChE), butyrylcholinesterase (BuChE), and monoamine oxidase B (MAO‐B). Compounds THU‐4 and THU‐8 were found to be the most potent inhibitors for the cholinesterases and MAO‐B, respectively. The docking studies were also employed to evaluate the binding modes of the most active compounds with AChE, BuChE, and MAO‐B. Furthermore, the moderate‐to‐strong activities of the compounds were also displayed in amyloid‐beta inhibition and antioxidant assay systems. The results pointed out that the urolithin scaffold can be employed in drug design studies for the development of multitarget ligands acting on various cascades shown to be important within the pathophysiology of Alzheimer's disease.